Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FAPI Molecular Imaging for Diagnosis of the CMS4 Unfavorable Colorectal Cancer Subtype

NCT06191120 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT06191120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06191120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FAPI Molecular Imaging for Diagnosis of the CMS4 Unfavorable Colorectal Cancer Subtype
Lead sponsor
UMC Utrecht
Phase
Not applicable
Overall status
Recruiting
Start date
August 5, 2024
Completion date
July 31, 2031
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer to liver, metastatic colorectal cancer